NAV22/01/2025 Diferencia+10.1699 Tipo de beneficio Enfoque de la inversión Sociedad de fondos
1,778.2100SEK +0.58% reinvestment Equity Worldwide C WORLDWIDE FUND M. 

Estrategia de inversión

We aim to achieve a long-term growth of your capital by investing in shares of a limited number of attractive companies operating in the healthcare sector, worldwide. The Sub-Fund focuses on large and medium size companies which account for at least 75% of our investments. Smaller size companies may represent up to 25% of the investments. Our investment decisions are based on a thorough financial analysis of companies operating in the healthcare sector, combined with an evaluation of financial markets in the pharmaceutical, medical technology, biotechnology and medical service sectors. It allows us to build a concentrated portfolio of companies of which we have a detailed knowledge and we intimately know to represent the most promising investment opportunities on the long term.
 

Objetivo de inversión

We aim to achieve a long-term growth of your capital by investing in shares of a limited number of attractive companies operating in the healthcare sector, worldwide.
 

Datos maestros

Tipo de beneficio: reinvestment
Categoría de fondos: Equity
Región: Worldwide
Sucursal: Sector Health / Pharma
Punto de referencia: MSCI World Healthcare Index
Inicio del año fiscal: 01/01
Última distribución: -
Banco depositario: Bank of New York Mellon SA/NV
País de origen: Luxembourg
Permiso de distribución: Germany, Czech Republic
Gestor de fondo: Mikael Svensson, Ulf Arvidsson
Volumen de fondo: -
Fecha de fundación: 01/12/1998
Enfoque de la inversión: -

Condiciones

Recargo de emisión: 0.00%
Max. Comisión de administración: 1.60%
Inversión mínima: 10,000.00 SEK
Deposit fees: 0.05%
Cargo por amortización: 0.00%
Prospecto simplificado: -
 

Sociedad de fondos

Fondos de empresa: C WORLDWIDE FUND M.
Dirección: P.O. Box 1141, 1011, Luxembourg
País: Luxembourg
Internet: www.carnegieam.com
 

Activos

Stocks
 
100.00%

Países

Global
 
100.00%

Sucursales

Pharma/Biotechnology
 
30.50%
Healthcare appliances
 
27.40%
Pharma, production
 
22.60%
commercial service
 
19.40%
Otros
 
0.10%